Perspective Therapeutics Inc. buy BiotechBee
Start price
08.09.24
/
60%
€14.20
Target price
31.07.27
€20.00
Performance (%)
-76.20%
End price
14.12.24
€3.38
Summary
This prediction ended on 14.12.24 with a price of €3.38. Massive losses of -76.20% were the result for the BUY prediction by BiotechBee. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Perspective Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % |
According to BiotechBee what are the pros and cons of Perspective Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Perspective Therapeutics Inc. diskutieren
Buy mit Kursziel 20,0